Post by
subaru1i on Apr 03, 2024 7:58pm
Listen up folks and listen WELL: As disclosed by the CEO of
LABS we now have 3 MAJOR announcments pending, not including the name of their global traditional partner.
1) The approval of 2 drugs for the South American market, one already approved
2) The approval by the FDA of a new generic form of Epidiolex
3) DEA rescheduling of cannabis from 1 to 3 for pharmaceutical applications
Anybody whining now about LABS has a hidden motive behind it and the ignore button is a wonderful feature which I recommend all longs to use as well. Let them talk to themselves.
Comment by
okgonow on Apr 04, 2024 1:32am
All Insaid was that it is frustrating to see MPL price not move at least a little further north with the whole sector catching a bit of fire! It is the duty of the management team of a publicly traded company not only to run the company well but also create shareholder value .....that means SP appreciation!!!
Comment by
1hot-techwoman on Apr 04, 2024 6:45am
This is true okgonow! We will have our day :) Patience :)